한글목차

치료용 혈액성분채집술 시장 규모는 의료 기술의 발전과 정밀의료의 통합에 힘입어 2025년 32억 2,000만 달러에서 2032년 53억 달러로 확대될 것으로 예상되며, CAGR은 7.3%로 예측됩니다.

치료용 혈액성분채집술은 혈류에서 유해물질을 선택적으로 제거하는 의료 과정으로 자가면역질환, 신경질환, 혈액 관련 질환 등 다양한 질환의 치료에 도움이 됩니다. 의료기기의 혁신과 함께 이러한 질환의 유병률 증가가 시장 성장에 크게 기여하고 있습니다. 치료용 혈액성분채집술 시장은 기술 발전, 질병 유병률 증가, 정밀의료의 채택 확대로 인해 크게 확대될 것으로 예상됩니다. 주요 기업들이 조사개발에 투자하고 있기 때문에 향후 몇 년 동안 이 산업은 크게 성장할 준비가 되어 있습니다.

자동화된 혈액성분채집술 시스템과 멤브레인 기반 여과 기술의 채택으로 치료의 효율성, 안전성, 정확성이 향상되고 있습니다. 자가면역질환 및 혈액질환의 증가로 인해 치료용 혈액성분채집술에 대한 수요가 증가하고 있습니다. 혈액성분채집술로 치료할 수 있는 질환에 걸리기 쉬운 노년층의 증가가 시장 확대를 촉진하고 있습니다. 혈액성분채집술의 장점에 대한 의료진의 인식이 높아지면서 보급이 촉진되고 있습니다.

세계의 치료용 혈액성분채집술 시장에 대해 조사했으며, 시장 개요와 함께 시술 유형별, 기술별, 용도별, 최종사용자별, 지역별 동향, 시장 진입 기업의 경쟁 동향 등의 정보를 전해드립니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 정의와 세분화
• 시장 역학
• 밸류체인 분석
• Porter's Five Forces 분석
• COVID-19의 영향 분석
• 우크라이나·러시아 분쟁의 영향
• 경제 개요
• PESTLE 분석

제3장 가격 분석, 2019-2023년

제4장 세계의 치료용 혈액성분채집술 시장 전망, 2019-2032년

• 2019-2032년의 세계 치료용 혈액성분채집술 시장 전망, 시술 유형별, 금액(10억 달러), 수량(상자)
• 2019-2032년의 세계 치료용 혈액성분채집술 시장 전망, 기술별, 금액(10억 달러), 수량(상자)
• 2019-2032년의 세계 치료용 혈액성분채집술 시장 전망, 용도별, 금액(10억 달러), 수량(상자)
• 2019-2032년의 세계 치료용 혈액성분채집술 시장 전망, 최종사용자별, 금액(10억 달러), 수량(상자)
• 2019-2032년의 세계 치료용 혈액성분채집술 시장 전망, 지역별, 금액(10억 달러), 수량(상자)

제5장 북미의 치료용 혈액성분채집술 시장 전망, 2019-2032년

제6장 유럽의 치료용 혈액성분채집술 시장 전망, 2019-2032년

제7장 아시아태평양의 치료용 혈액성분채집술 시장 전망, 2019-2032년

제8장 라틴아메리카의 치료용 혈액성분채집술 시장 전망, 2019-2032년

제9장 중동 및 아프리카의 치료용 혈액성분채집술 시장 전망, 2019-2032년

제10장 경쟁 구도

• 시술 유형별 vs 기술별 히트맵
• 기업 시장 점유율 분석, 2024년
• 경쟁 대시보드
• 기업 개요
  • Asahi Kasei Medical Co.
  • Haemonetics Corporation
  • Miltenyi Biotec
  • Cerus Corporation
  • Terumo BCT Inc.
  • Fresenius Kabi USA
  • Terumo BCT
  • B. Braun Melsungen AG
  • Nikkiso Co. Ltd.
  • Medica S.p.A.
  • Baxter Healthcare Corporation
  • Kawasumi Laboratories Inc.
  • Therakos Incorporation

제11장 부록

영문목차

The therapeutic apheresis market is on track for remarkable expansion, propelled by advancements in medical technology and the growing integration of precision medicine. With an anticipated CAGR of 7.3%, the market is projected to reach USD 3.22 billion by 2025 and further increase to USD 5.30 billion by 2032.

Market Overview

Therapeutic apheresis is a medical process that selectively removes harmful substances from the bloodstream, aiding in the treatment of various conditions such as autoimmune disorders, neurological ailments, and blood-related diseases. The increasing prevalence of these conditions, alongside innovations in medical equipment, is significantly contributing to market growth. The therapeutic apheresis market is set for significant expansion, driven by technological advancements, rising disease prevalence, and growing adoption of precision medicine. With major players investing in research and development, the industry is poised for transformative growth in the coming years.

Key Market Drivers

• Advancements in Technology: The adoption of automated apheresis systems and membrane-based filtration technologies has enhanced efficiency, safety, and precision in treatment.
• Increasing Disease Incidence: Rising cases of autoimmune and hematologic conditions are driving the demand for therapeutic apheresis procedures.
• Aging Population: The increasing number of elderly individuals, who are more vulnerable to diseases treatable with apheresis, is fostering market expansion.
• Growing Awareness: Greater recognition among healthcare professionals regarding the benefits of apheresis is facilitating its widespread adoption.

Emerging Business Opportunities

• Integration into Precision Medicine: The use of therapeutic apheresis in personalized treatment plans is gaining momentum.
• Diversification of Applications: Beyond its traditional use in hematology and neurology, apheresis is being explored for applications in oncology and rare genetic conditions.
• Collaborative Growth: Strategic partnerships between healthcare providers, research institutions, and industry stakeholders are driving innovation and market penetration.

Regional Market Trends

• North America: Expected to maintain the largest share, supported by advanced healthcare infrastructure, high spending on medical treatments, and rapid technological adoption.
• Asia Pacific: Forecasted to witness the fastest growth due to increasing healthcare investments and rising awareness, especially in China and Japan.
• Europe: A well-regulated healthcare industry continues to provide steady market expansion.
• Other Regions (Latin America, , Middle East & Africa): Increasing demand for advanced healthcare solutions is spurring growth in these markets.

Leading Market Participants

Key companies are focusing on research, innovation, and geographical expansion to solidify their market presence. Major players include:

• Asahi Kasei Medical Co.
• Haemonetics Corporation
• Miltenyi Biotec
• Cerus Corporation
• Terumo BCT Inc.
• Fresenius Kabi USA
• B. Braun Melsungen AG
• Nikkiso Co. Ltd.
• Medica S.p.A.
• Baxter Healthcare Corporation
• Kawasumi Laboratories Inc.
• Therakos Incorporation

Recent Industry Developments

• New Partnership: Terumo Blood and Cell Technologies collaborated with Eliaz Therapeutics to develop a novel therapeutic apheresis treatment for acute kidney injury (AKI).
• Investment in Innovation: NHS England has approved Terumo's Spectra Optia Apheresis System for treating sickle cell disease, significantly increasing its adoption across various institutions.

Market Segmentation

By Procedure Type:

• Therapeutic Plasma Exchange (TPE)
• Red Blood Cell Exchange (RBCX)
• Cellular Depletions

By Technology:

• Centrifugation
• Membrane Filtration

By Application:

• Hematology
• Neurology
• Nephrology
• Rheumatology
• Oncology
• Others

By End User:

• Hospitals
• Blood Banks
• Specialty Clinics

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Therapeutic Apheresis Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value and Volume, 2024
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. COVID-19 Impact Analysis
  • 2.5.1. Supply
  • 2.5.2. Demand
• 2.6. Impact of Ukraine-Russia Conflict
• 2.7. Economic Overview
  • 2.7.1. World Economic Projections
• 2.8. PESTLE Analysis

3. Price Analysis, 2019 - 2023

• 3.1. Global Average Price Analysis by Procedure Type, 2019 - 2023
• 3.2. Prominent Factor Affecting Therapeutic Apheresis Prices
• 3.3. Global Average Price Analysis by Region

4. Global Therapeutic Apheresis Market Outlook, 2019 - 2032

• 4.1. Global Therapeutic Apheresis Market Outlook, by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 4.1.1. Key Highlights
    • 4.1.1.1. Therapeutic Plasma Exchange (TPE)
    • 4.1.1.2. Red Blood Cell Exchange (RBCX)
    • 4.1.1.3. Cellular Depletions
• 4.2. Global Therapeutic Apheresis Market Outlook, by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 4.2.1. Key Highlights
    • 4.2.1.1. Centrifugation
    • 4.2.1.2. Membrane filtration
• 4.3. Global Therapeutic Apheresis Market Outlook, by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 4.3.1. Key Highlights
    • 4.3.1.1. Hematology
    • 4.3.1.2. Neurology
    • 4.3.1.3. Nephrology
    • 4.3.1.4. Rheumatology
    • 4.3.1.5. Oncology
    • 4.3.1.6. Others
• 4.4. Global Therapeutic Apheresis Market Outlook, by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 4.4.1. Key Highlights
    • 4.4.1.1. Hospitals
    • 4.4.1.2. Blood banks
    • 4.4.1.3. Specialty clinics
• 4.5. Global Therapeutic Apheresis Market Outlook, by Region, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 4.5.1. Key Highlights
    • 4.5.1.1. North America
    • 4.5.1.2. Europe
    • 4.5.1.3. Asia Pacific
    • 4.5.1.4. Latin America
    • 4.5.1.5. Middle East & Africa

5. North America Therapeutic Apheresis Market Outlook, 2019 - 2032

• 5.1. North America sTherapeutic Apheresis Market Outlook, by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 5.1.1. Key Highlights
    • 5.1.1.1. Therapeutic Plasma Exchange (TPE)
    • 5.1.1.2. Red Blood Cell Exchange (RBCX)
    • 5.1.1.3. Cellular Depletions
• 5.2. North America Therapeutic Apheresis Market Outlook, by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 5.2.1. Key Highlights
    • 5.2.1.1. Centrifugation
    • 5.2.1.2. Membrane filtration
• 5.3. North America Therapeutic Apheresis Market Outlook, by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 5.3.1. Key Highlights
    • 5.3.1.1. Hematology
    • 5.3.1.2. Neurology
    • 5.3.1.3. Nephrology
    • 5.3.1.4. Rheumatology
    • 5.3.1.5. Oncology
    • 5.3.1.6. Others
• 5.4. North America Therapeutic Apheresis Market Outlook, by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 5.4.1. Key Highlights
    • 5.4.1.1. Hospitals
    • 5.4.1.2. Blood banks
    • 5.4.1.3. Specialty clinics
  • 5.4.2. Attractiveness Analysis
• 5.5. North America Therapeutic Apheresis Market Outlook, by Country, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 5.5.1. Key Highlights
    • 5.5.1.1. U.S. Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 5.5.1.2. U.S. Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 5.5.1.3. U.S. Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 5.5.1.4. U.S. Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 5.5.1.5. Canada Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 5.5.1.6. Canada Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 5.5.1.7. Canada Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 5.5.1.8. Canada Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032

6. Europe Therapeutic Apheresis Market Outlook, 2019 - 2032

• 6.1. Europe Therapeutic Apheresis Market Outlook, by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 6.1.1. Key Highlights
    • 6.1.1.1. Therapeutic Plasma Exchange (TPE)
    • 6.1.1.2. Red Blood Cell Exchange (RBCX)
    • 6.1.1.3. Cellular Depletions
• 6.2. Europe Therapeutic Apheresis Market Outlook, by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 6.2.1. Key Highlights
    • 6.2.1.1. Centrifugation
    • 6.2.1.2. Membrane filtration
• 6.3. Europe Therapeutic Apheresis Market Outlook, by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 6.3.1. Key Highlights
    • 6.3.1.1. Hematology
    • 6.3.1.2. Neurology
    • 6.3.1.3. Nephrology
    • 6.3.1.4. Rheumatology
    • 6.3.1.5. Oncology
    • 6.3.1.6. Others
• 6.4. Europe Therapeutic Apheresis Market Outlook, by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 6.4.1. Key Highlights
    • 6.4.1.1. Hospitals
    • 6.4.1.2. Blood banks
    • 6.4.1.3. Specialty clinics
  • 6.4.2. Attractiveness Analysis
• 6.5. Europe Therapeutic Apheresis Market Outlook, by Country, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 6.5.1. Key Highlights
    • 6.5.1.1. Germany Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.2. Germany Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.3. Germany Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.4. Germany Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.5. U.K. Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.6. U.K. Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.7. U.K. Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.8. U.K. Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.9. France Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.10. France Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.11. France Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.12. France Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.13. Italy Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.14. Italy Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.15. Italy Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.16. Italy Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.17. Turkey Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.18. Turkey Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.19. Turkey Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.20. Turkey Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.21. Russia Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.22. Russia Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.23. Russia Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.24. Russia Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.25. Rest of Europe Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.26. Rest of Europe Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.27. Rest of Europe Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1.28. Rest of Europe Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032

7. Asia Pacific Therapeutic Apheresis Market Outlook, 2019 - 2032

• 7.1. Asia Pacific Therapeutic Apheresis Market Outlook, by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 7.1.1. Key Highlights
    • 7.1.1.1. Therapeutic Plasma Exchange (TPE)
    • 7.1.1.2. Red Blood Cell Exchange (RBCX)
    • 7.1.1.3. Cellular Depletions
• 7.2. Asia Pacific Therapeutic Apheresis Market Outlook, by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 7.2.1. Key Highlights
    • 7.2.1.1. Centrifugation
    • 7.2.1.2. Membrane filtration
• 7.3. Asia Pacific Therapeutic Apheresis Market Outlook, by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 7.3.1. Key Highlights
    • 7.3.1.1. Hematology
    • 7.3.1.2. Neurology
    • 7.3.1.3. Nephrology
    • 7.3.1.4. Rheumatology
    • 7.3.1.5. Oncology
    • 7.3.1.6. Others
• 7.4. Asia Pacific Therapeutic Apheresis Market Outlook, by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 7.4.1. Key Highlights
    • 7.4.1.1. Hospitals
    • 7.4.1.2. Blood banks
    • 7.4.1.3. Specialty clinics
  • 7.4.2. Attractiveness Analysis
• 7.5. Asia Pacific Therapeutic Apheresis Market Outlook, by Country, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 7.5.1. Key Highlights
    • 7.5.1.1. China Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1.2. China Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1.3. China Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1.4. China Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1.5. Japan Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1.6. Japan Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1.7. Japan Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1.8. Japan Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1.9. South Korea Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1.10. South Korea Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1.11. South Korea Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1.12. South Korea Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1.13. India Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1.14. India Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1.15. India Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1.16. India Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1.17. Southeast Asia Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1.18. Southeast Asia Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1.19. Southeast Asia Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1.20. Southeast Asia Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1.21. Rest of Asia Pacific Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1.22. Rest of Asia Pacific Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1.23. Rest of Asia Pacific Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1.24. Rest of Asia Pacific Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032

8. Latin America Therapeutic Apheresis Market Outlook, 2019 - 2032

• 8.1. Latin America Therapeutic Apheresis Market Outlook, by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 8.1.1. Key Highlights
    • 8.1.1.1. Therapeutic Plasma Exchange (TPE)
    • 8.1.1.2. Red Blood Cell Exchange (RBCX)
    • 8.1.1.3. Cellular Depletions
• 8.2. Latin America Therapeutic Apheresis Market Outlook, by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 8.2.1. Key Highlights
    • 8.2.1.1. Centrifugation
    • 8.2.1.2. Membrane filtration
• 8.3. Latin America Therapeutic Apheresis Market Outlook, by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 8.3.1. Key Highlights
    • 8.3.1.1. Hematology
    • 8.3.1.2. Neurology
    • 8.3.1.3. Nephrology
    • 8.3.1.4. Rheumatology
    • 8.3.1.5. Oncology
    • 8.3.1.6. Others
• 8.4. Latin America Therapeutic Apheresis Market Outlook, by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 8.4.1. Key Highlights
    • 8.4.1.1. Hospitals
    • 8.4.1.2. Blood banks
    • 8.4.1.3. Specialty clinics
  • 8.4.2. Attractiveness Analysis
• 8.5. Latin America Therapeutic Apheresis Market Outlook, by Country, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 8.5.1. Key Highlights
    • 8.5.1.1. Brazil Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.5.1.2. Brazil Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.5.1.3. Brazil Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.5.1.4. Brazil Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.5.1.5. Mexico Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.5.1.6. Mexico Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.5.1.7. Mexico Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.5.1.8. Mexico Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.5.1.9. Argentina Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.5.1.10. Argentina Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.5.1.11. Argentina Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.5.1.12. Argentina Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.5.1.13. Rest of Latin America Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.5.1.14. Rest of Latin America Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.5.1.15. Rest of Latin America Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.5.1.16. Rest of Latin America Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032

9. Middle East & Africa Therapeutic Apheresis Market Outlook, 2019 - 2032

• 9.1. Middle East & Africa Therapeutic Apheresis Market Outlook, by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 9.1.1. Key Highlights
    • 9.1.1.1. Therapeutic Plasma Exchange (TPE)
    • 9.1.1.2. Red Blood Cell Exchange (RBCX)
    • 9.1.1.3. Cellular Depletions
• 9.2. Middle East & Africa Therapeutic Apheresis Market Outlook, by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 9.2.1. Key Highlights
    • 9.2.1.1. Centrifugation
    • 9.2.1.2. Membrane filtration
• 9.3. Middle East & Africa Therapeutic Apheresis Market Outlook, by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 9.3.1. Key Highlights
    • 9.3.1.1. Hematology
    • 9.3.1.2. Neurology
    • 9.3.1.3. Nephrology
    • 9.3.1.4. Rheumatology
    • 9.3.1.5. Oncology
    • 9.3.1.6. Others
• 9.4. Middle East & Africa Therapeutic Apheresis Market Outlook, by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 9.4.1. Key Highlights
    • 9.4.1.1. Hospitals
    • 9.4.1.2. Blood banks
    • 9.4.1.3. Specialty clinics
  • 9.4.2. Attractiveness Analysis
• 9.5. Middle East & Africa Therapeutic Apheresis Market Outlook, by Country, Value (US$ Bn) and Volume (Box), 2019 - 2032
  • 9.5.1. Key Highlights
    • 9.5.1.1. GCC Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.5.1.2. GCC Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.5.1.3. GCC Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.5.1.4. GCC Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.5.1.5. South Africa Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.5.1.6. South Africa Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.5.1.7. South Africa Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.5.1.8. South Africa Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.5.1.9. Egypt Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.5.1.10. Egypt Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.5.1.11. Egypt Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.5.1.12. Egypt Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.5.1.13. Nigeria Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.5.1.14. Nigeria Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.5.1.15. Nigeria Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.5.1.16. Nigeria Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.5.1.17. Rest of Middle East & Africa Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.5.1.18. Rest of Middle East & Africa Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.5.1.19. Rest of Middle East & Africa Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.5.1.20. Rest of Middle East & Africa Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032

10. Competitive Landscape

• 10.1. By Procedure Type vs by Technology Heatmap
• 10.2. Company Market Share Analysis, 2024
• 10.3. Competitive Dashboard
• 10.4. Company Profiles
  • 10.4.1. Asahi Kasei Medical Co.
    • 10.4.1.1. Company Overview
    • 10.4.1.2. Product Portfolio
    • 10.4.1.3. Financial Overview
    • 10.4.1.4. Business Strategies and Development
  • 10.4.2. Haemonetics Corporation
    • 10.4.2.1. Company Overview
    • 10.4.2.2. Product Portfolio
    • 10.4.2.3. Financial Overview
    • 10.4.2.4. Business Strategies and Development
  • 10.4.3. Miltenyi Biotec
    • 10.4.3.1. Company Overview
    • 10.4.3.2. Product Portfolio
    • 10.4.3.3. Financial Overview
    • 10.4.3.4. Business Strategies and Development
  • 10.4.4. Cerus Corporation
    • 10.4.4.1. Company Overview
    • 10.4.4.2. Product Portfolio
    • 10.4.4.3. Financial Overview
    • 10.4.4.4. Business Strategies and Development
  • 10.4.5. Terumo BCT Inc.
    • 10.4.5.1. Company Overview
    • 10.4.5.2. Product Portfolio
    • 10.4.5.3. Financial Overview
    • 10.4.5.4. Business Strategies and Development
  • 10.4.6. Fresenius Kabi USA
    • 10.4.6.1. Company Overview
    • 10.4.6.2. Product Portfolio
    • 10.4.6.3. Financial Overview
    • 10.4.6.4. Business Strategies and Development
  • 10.4.7. Terumo BCT
    • 10.4.7.1. Company Overview
    • 10.4.7.2. Product Portfolio
    • 10.4.7.3. Financial Overview
    • 10.4.7.4. Business Strategies and Development
  • 10.4.8. B. Braun Melsungen AG
    • 10.4.8.1. Company Overview
    • 10.4.8.2. Product Portfolio
    • 10.4.8.3. Financial Overview
    • 10.4.8.4. Business Strategies and Development
  • 10.4.9. Nikkiso Co. Ltd.
    • 10.4.9.1. Company Overview
    • 10.4.9.2. Product Portfolio
    • 10.4.9.3. Financial Overview
    • 10.4.9.4. Business Strategies and Development
  • 10.4.10. Medica S.p.A.
    • 10.4.10.1. Company Overview
    • 10.4.10.2. Product Portfolio
    • 10.4.10.3. Financial Overview
    • 10.4.10.4. Business Strategies and Development
  • 10.4.11. Baxter Healthcare Corporation
    • 10.4.11.1. Company Overview
    • 10.4.11.2. Product Portfolio
    • 10.4.11.3. Financial Overview
    • 10.4.11.4. Business Strategies and Development
  • 10.4.12. Kawasumi Laboratories Inc.
    • 10.4.12.1. Company Overview
    • 10.4.12.2. Product Portfolio
    • 10.4.12.3. Financial Overview
    • 10.4.12.4. Business Strategies and Development
  • 10.4.13. Therakos Incorporation
    • 10.4.13.1. Company Overview
    • 10.4.13.2. Product Portfolio
    • 10.4.13.3. Financial Overview
    • 10.4.13.4. Business Strategies and Development

11. Appendix

• 11.1. Research Methodology
• 11.2. Report Assumptions
• 11.3. Acronyms and Abbreviations